Outpatient Autologous Stem Cell Transplants for Multiple Myeloma- Analysis of Safety and Outcomes in a Tertiary Care Center
ConclusionOutpatient ASCT is a safe and feasible treatment strategy with low TRM. Overall resource utilization are significantly lower than inpatient auto-transplantation: however, this requires a multidisciplinary approach with close follow up
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Amyloidosis | Cancer & Oncology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants